Floatz logo

METHOTREXATE

Hurler Disease

Children's Hospital Los AngelesSmall moleculePhase 1/2Dormant
CCC
52/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
37/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Hurler Disease cohort.

Asset / SponsorPhaseRating
CYCLOSPORIN A
Masonic Cancer Center, University of Minnesota
Phase 2BB
IMMUNOGLOBULIN G1 (HUMAN-RAT MONOCLONAL CAMPATH-1H .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD52), DISULFIDE WITH HUMAN-RAT MONOCLONAL CAMPATH-1H LIGHT CHAIN, DIMER
Masonic Cancer Center, University of Minnesota
Phase 2B
Evomela
Children's Hospital Los Angeles
Phase 1/2CCC
TACROLIMUS
Children's Hospital Los Angeles
Phase 1/2CCC
PREDNISONE TABLETS
Children's Hospital Los Angeles
Phase 1/2CCC

Same molecule, other indications

METHOTREXATE is also rated in:

adult acute lymphoblastic leukemiaDormant
BBB
Indicative ·
79 / 100
View asset →
B-cell childhood acute lymphoblastic leukemiaDormant
BBB
Indicative ·
78 / 100
View asset →
acute promyelocytic leukemiaDormant
BBB
Indicative ·
76 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →